You are here

Article Text

Article menu
Download PDFPDF
Diagnosis
Cross-sectional study
Ultrasound-based IOTA simple rules allow accurate malignancy risk estimation for adnexal masses
  1. Juan Luis Alcázar
  1. Department of Obstetrics and Gynecology, University of Navarre, Pamplona, Spain
  1. Correspondence to: Dr Juan Luis Alcázar, Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Avenida Pio XII 36, Pamplona 31008, Spain; jlalcazar{at}unav.es

http://dx.doi.org/10.1136/ebmed-2016-110459

Statistics from Altmetric.com

    Commentary on: Timmerman D, Van Calster B, Testa A, et al. Predicting the risk of malignancy in adnexal masses based on the simple rules from the international ovarian tumor analysis group. Am J Obstet Gynecol 2016;214:424–37OpenUrlCrossRefPubMed.

    Context

    Adnexal masses are a common clinical problem, with ovarian cancer remaining as the most lethal gynaecological malignancy. Evidence shows that women with ovarian cancer should be primarily treated at specialised centres,1 while women with benign adnexal masses can be treated by general gynaecologists.2 Accurate diagnosis is essential for adequate triage. Currently, the best method for discriminating benign from malignant adnexal masses is ultrasound assessment by an expert examiner.3 The international ovarian tumour analysis (IOTA) group has proposed a simple risk estimation approach based on ultrasound features of the ovarian tumours (five benign and five malignant), …

    View Full Text

    Footnotes

    • Twitter Follow Juan Luis Alcázar at @Juan_L_Alcazar

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/